P
ELV icon

&Partners’s Elevance Health ELV Stock Holding History

&Partners’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.68M Buy
17,308
+5,168
+43% +$1.92M 0.03% 502
2026
Q1 		$3.55M Sell
12,140
-96
-0.8% -$31.6K 0.02% 652
2025
Q4 		$4.29M Buy
12,236
+2,166
+22% +$732K 0.02% 553
2025
Q3 		$3.26M Sell
10,070
-154
-2% -$47.9K 0.02% 559
2025
Q2 		$4M Buy
10,224
+2,165
+27% +$871K 0.03% 428
2025
Q1 		$3.48M Buy
8,059
+1,906
+31% +$765K 0.04% 382
2024
Q4 		$2.28M Sell
6,153
-115
-2% -$48.1K 0.03% 458
2024
Q3 		$3.26M Buy
6,268
+2,488
+66% +$1.33M 0.06% 272
2024
Q2 		$2.05M Buy
3,780
+2,591
+218% +$1.37M 0.09% 211
2024
Q1 		$617K Buy
1,189
+661
+125% +$329K 0.09% 230
2023
Q4 		$249K Sell
528
-48
-8% -$22.2K 0.06% 240
2023
Q3 		$251K Hold
576
– – 0.12% 141
2023
Q2 		$256K Buy
576
+57
+11% +$26.3K 0.11% 145
2023
Q1 		$238K Buy
519
+1
+0.2% +$476 0.11% 143
2022
Q4 		$266K Buy
518
+469
+957% +$238K 0.13% 137
2022
Q3 		$254K Buy
+49
New +$23.4K 0.15% 136

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

&Partners's ELV Position: Q2 2026 in Review

&Partners increased its Elevance Health (ELV) stake by 43% in Q2 2026, buying an estimated $1.92M and bringing the position to 17,308 shares worth $6.68M. The position accounts for 0.03% of the portfolio, ranked #502.

&Partners first reported a position in ELV in Q3 2022 and has held it in 16 quarters since. 1,607 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • &Partners held 17,308 shares of Elevance Health worth $6.68M as of Q2 2026.
  • &Partners bought 5,168 Elevance Health shares in Q2 2026, an estimated $1.92M.
  • Elevance Health made up 0.03% of &Partners's portfolio in Q2 2026, its #502 holding.
  • &Partners first reported a position in Elevance Health in Q3 2022 and has held it in 16 quarters since.
  • 1,607 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on &Partners's 13F filing for Q2 2026, filed 14 Aug 2026.